Covington Associates advises Cosman in Boston Scientific buyout

Covington Associates said late last month it acted as an exclusive advisor to radio-frequency ablation system manufacturer Cosman Medical during its acquisition by Boston Scientific (NYSE:BSX). Through the acquisition, Cosman Medical’s team and products were folded into Boston Scientific’s neuromodulation business, the company said. “This acquisition is a natural extension of our current product portfolio and

CVRx secures millions in new financing

CVRx, a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans to use the proceeds for the primary purposes of completing the Baroreflex Activation Therapy for Heart Failure Pivotal Clinical Trial (BeAT-HF) and expanding its global commercial activities. Equity financing The company has completed

Reimbursement thinking for medtech designers and engineers

Reimbursement is a dreaded topic for designers and engineers, says Mike Drues, president of Vascular Sciences. “It can be boring because people approach it like it is a box to check.” But, he says, it’s not just about the money and checking boxes. “Engineers have to care about reimbursement, because it’s fundamental to ensuring that

FlexDex Surgical closes $5m Series B, preps launch of laparoscopic tools

FlexDex Surgical said today that it raised a $5 million Series B round it plans to use to advance the laparoscopic surgery tools it’s developing. The round was led by current investors, including co-founders technology chief Shorya Awtar, chief marketing officer Greg Bowles and Dr. James Geiger of the University of Michigan; plus board members, individual

TE Connectivity gains on Q3 earnings beat

TE Connectivity (NYSE:TEL) shares are up today after the contract manufacturing giant beat expectations with its fiscal third-quarter earnings and said it would acquire German connector maker Intercontec Group. Schaffhausen, Switzerland-based TE Connectivity posted profits of $839 million, or $2.19 per share, on sales of $3.12 billion for the three months ended June 24, for a bottom-line

Medical Alley’s Minnesota region raises $227 Million in the first half of 2016

Minnesota continues to be a hub for health technology innovation and financial investment, with 2016 being a breakthrough year for the digital health sector. Detailed in the Medical Alley Association’s Q2 Quarterly Investment Report, the start of 2016 represents record investment in health technology in Minnesota, raising $227 mil in the first half of the

Reimbursement thinking for medtech designers and engineers

Reimbursement: It’s a dreaded topic for designers and engineers, says Mike Drues, president of Vascular Sciences. “It can be boring because people approach it like it is a box to check.” But he says, it’s not just about the money and checking boxes. “Engineers have to care about reimbursement because it is fundamental to ensuring

SEC issues new guidance on non-GAAP financial measures

On May 17, 2016, the Division of Corporation Finance of the Securities and Exchange Commission (SEC) issued guidance in the form of 12 new and revised Compliance & Disclosure Interpretations (C&DIs), regarding the use of non-GAAP financial measures by public companies under Regulation G and Item 10(e) of Regulation S-K. Regulation G generally applies to

Tepha buys its way out of Metabolix bioresorbables deal

Absorbable biomaterial developer Metabolix said it amended its license agreement with medical device company Tepha Medical Devices, forgoing future royalties and providing 2 additional Metabolix production strains and related IP in exchange for $2 million. Metabolix’s agreement with Lexington, Mass.-based Tepha includes the licensing of its Metabolix PHA biopolymer technology for use in certain medical applications,

Emerging countries will be fundamental to growth of renal dialysis market

The growth of the global renal dialysis market, which encompasses both the service and equipment segments, was valued at $77 billion in 2015, and is set to expand to $101.9 billion by 2022, will be largely driven by emerging markets such as China, Brazil and India over the next seven years, according to an analyst

FreshLoc Technologies and Wello receive funding for expansion

FreshLoc Technologies and Wello, developers in specialized temperature monitoring in healthcare, are pleased to announce the close of a new round of funding, in support of their rapid growth rate over the past two years at an amount in the low seven-figure range. The current growth rate has exceeded 60% and all earlier plans. Nationwide expansion

Hamilton Thorne announces operational and financial results for the quarter ended March 31, 2016

Hamilton Thorne, a provider of precision laser devices and advanced image analysis systems for the assisted reproductive technologies and developmental biology research markets, today reported operational and financial results for the quarter ended March 31, 2016. Hamilton Thorne reported total sales of $2.029 million for the quarter-ended March 31, 2016, a decrease of $68,072 (3.2%)

Fine Needle Aspiration market to stagnate as doctors shift to Core Needle Biopsy

The Fine Needle Aspiration (FNA) segment of the biopsy market is set to remain relatively stagnant over the next few years, rising only slightly from $56 million in 2015 to $59.2 million in 2022, at a Compound Annual Growth Rate (CAGR) of 0.81%, according to research and consulting firm GlobalData. The company’s report states that

Milestone Scientific reports increase in revenue for the first quarter of 2016

Milestone Scientific, a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, announced financial results for the first quarter ending March 31, 2016. First Quarter 2016 Financial Highlights Revenue for the first quarter of 2016 increased 29% to $3.6 million Domestic handpiece sales increased 129% to $988,000 Domestic

Axion BioSystems completes successful equity financing

Axion BioSystems, a manufacturer of the Maestro multiwell microelectrode array (MEA) platform, is pleased to announce that the Company successfully closed a $6 million equity financing. The additional capital will accelerate the growth of Axion’s core life science instrumentation product line. The Georgia Research Alliance (GRA) has supported Axion since it was founded in 2008. In this